Open access · OA
via OpenAlex
SUPPRESSION OF SHC ADAPTOR PROTEIN AS A PHARMACOLOGICAL INTERVENTION TO AMELIORATE AGE-STRESS
Tanuja Harshani Peiris, Pankaj Kapahi
Innovation in Aging · 2017
Abstract
Advanced glycation end products have pathogenic implications towards diabetes, liver diseases and various other neurodegenerative diseases. In particular vascular complications that arise due to diabetes involves neuropathy, nephropathy, retinopathy and vitreopathy that lead to renal diseases and blindness. AGEs are endogenous products created by maillard reaction and several pathways including the glyoxalase I and aldo keto reductases are involved with detoxification of the AGEs. A recent study showed less circulating and tissue AGEs in p66Shc knockout mice compared to WT mice. A candidate genetic screen for worm orthologs of human genes associated with diabetic complications identified C. elegans SHC-1 as a strong modulator of pathogenic phenotypes in glod-4 mutants (C. elegans model lacking a functional glyoxalase gene). These glod-4 mutants maintain elevated AGEs, sensitivity to touch, and decreased lifespan. However RNAi against the Caenorhabditis elegans shc-1 gene and Acarbose and Idebenone discovered as SHC protein binders increases the lifespan of these glod-4 mutants. Thus we hypothesize that inhibition of SHC-1 may play an indispensable role in preventing AGE accumulation and AGE-stress. Thus in this study we propose to establish the mechanism by which shc modulates AGE accumulation and lifespan in C. elegans. Further we will Study SHC inhibitors (and or diets that modulate SHC) as pharmacological intervention to ameliorate AGE-stress and increase healthspan(definition) and lifespan.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/geroni/igx004.4388
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Peiris, T.H., & Kapahi, P. (2017). SUPPRESSION OF SHC ADAPTOR PROTEIN AS A PHARMACOLOGICAL INTERVENTION TO AMELIORATE AGE-STRESS. <em>Innovation in Aging</em>. https://doi.org/10.1093/geroni/igx004.4388
Vancouver
Peiris TH, Kapahi P. SUPPRESSION OF SHC ADAPTOR PROTEIN AS A PHARMACOLOGICAL INTERVENTION TO AMELIORATE AGE-STRESS. Innovation in Aging. 2017. doi:10.1093/geroni/igx004.4388.
BibTeX
@article{tanuja2017SUPPRE,
title = {SUPPRESSION OF SHC ADAPTOR PROTEIN AS A PHARMACOLOGICAL INTERVENTION TO AMELIORATE AGE-STRESS},
author = {Tanuja Harshani Peiris and Pankaj Kapahi},
journal = {Innovation in Aging},
year = {2017},
doi = {10.1093/geroni/igx004.4388},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Foods 2025
Open access · CC-BY
L-Theanine Extends the Lifespan of Caenorhabditis elegans by Reducing the End Products of Advanced Glycosylation
Oxidative Medicine and Cellular Longevity 2016
Open access · CC-BY
ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age‐Related Diseases
Redox Biology 2014
Open access · CC-BY
Role of advanced glycation end products in cellular signaling
Autophagy 2025
Open access · CC-BY
Autophagy and mitophagy at the synapse and beyond: implications for learning, memory and neurological disorders
PLoS ONE 2011
Open access · CC-BY
Autophagy Impairment Induces Premature Senescence in Primary Human Fibroblasts
Icahn School of Medicine at Mount Sinai 2010
Open access · US-GOV